NYSE · GENI

Genius Sports Limited

$7.45 +$0.97 (+14.97%) 1D Market open

Key Metrics

$1.73B
Market cap
P/E · TTM
$669.49M
Revenue · TTM
−$111.58M
Net income
EPS · TTM $-0.49
Dividend yield
Free cash flow $64.54M
Beta · 1Y 1.29
EBITDA · TTM −$80.81M
Gross margin 23.0%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 18
    The stock moved +22.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 18
  • Apr 10
    From its Jan 30 high, the share price fell 55%.

    Peak close $8.70 on Jan 30; trough close $3.92 on Apr 10. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -55%
  • Feb 5
    The stock moved -27.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 5

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$1.73B
Enterprise value$1.42B
Shares outstanding267.3M
52-wk range$3.83 – $13.73
Avg volume · 20D2.8M
Net cash $313.13M
Book value / share$3.21
ExchangeNYSE
About Genius Sports Limited
IPO dateApr 21, 2021
Employees2700

Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S2.59
P/FCF26.84
EV/EBITDA
EV/Sales2.12
Graham №

Profitability

Gross 23.0%
Operating -22.6%
Net -16.7%
FCF 9.6%
ROE / ROIC -17.2% · -33.4%

Financial Health

Current ratio1.56
Quick ratio1.56
Debt / equity0.00
Debt / EBITDA 0.00
Net cash $313.13M
Working capital$196.80M

Cash Flow · TTM

Operating CF $86.40M
Capex −$21.85M
Free cash flow $64.54M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

3 / 9
Weak fundamentals · 3 of 9 signals passing

Altman Z-Score

1.4
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2023-06-30 · computed by TickerWolf from SEC filings